PMID- 19937088 OWN - NLM STAT- MEDLINE DCOM- 20100908 LR - 20211020 IS - 1573-7373 (Electronic) IS - 0167-594X (Linking) VI - 98 IP - 1 DP - 2010 May TI - The cell-cycle kinetics of craniopharyngioma and its clinical significance. PG - 71-6 LID - 10.1007/s11060-009-0047-6 [doi] AB - Craniopharyngioma (CP) is a pathologically benign tumor with high incidence of recurrence and poor prognosis. DNA ploidy, S-phase fraction (SPF), and G2 phase/mitosis phase + S phase (G2/M + S) measured by flow cytometry (FCM) have been shown to correlate with cell cycle characteristics and clinical prognosis of other tumors. By use of FCM and terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL) peroxidase, we compared DNA content, SPF, G2/M + S, necrosis and apoptosis in non-recurrent and recurrent tumor cells of CP from 63 cases including 32 adamantine epitheliomas (AEs) and 31 squamous papillary tumors (SPTs), and the ultrastructure of the CP cell was observed by transmission electron microscopy. Although no obvious differences between DNA content and necrosis and apoptosis rate were observed in subgroups of CPs, SPF and G2/M + S for recurrent tumors were statistically higher than those for recurrence-free tumors, and the recurrence rate of AE tumors is higher than that of SPT. Therefore, CP cells are diploid, and SPF and G2/M + S are related to recurrence of CP. FAU - Xu, Jianguo AU - Xu J AD - Department of Neurosurgery, West China Hospital, Sichuan University, 37# Guoxuexiang Street, 610041, Chengdu, People's Republic of China. jianguoxu@mcwcums.com FAU - You, Chao AU - You C FAU - Zhou, Liangxue AU - Zhou L FAU - Li, Qiang AU - Li Q FAU - Zhou, Peizhi AU - Zhou P FAU - Chen, Ni AU - Chen N LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091124 PL - United States TA - J Neurooncol JT - Journal of neuro-oncology JID - 8309335 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Apoptosis/physiology MH - Cell Cycle/*physiology MH - Child MH - Child, Preschool MH - Craniopharyngioma/*pathology/*physiopathology/ultrastructure MH - Female MH - Flow Cytometry/methods MH - Follow-Up Studies MH - G2 Phase/physiology MH - Humans MH - In Situ Nick-End Labeling/methods MH - Male MH - Microscopy, Electron, Transmission/methods MH - Middle Aged MH - Pituitary Neoplasms/*pathology/*physiopathology/ultrastructure MH - Retrospective Studies MH - S Phase/physiology MH - Young Adult EDAT- 2009/11/26 06:00 MHDA- 2010/09/09 06:00 CRDT- 2009/11/26 06:00 PHST- 2009/05/29 00:00 [received] PHST- 2009/10/26 00:00 [accepted] PHST- 2009/11/26 06:00 [entrez] PHST- 2009/11/26 06:00 [pubmed] PHST- 2010/09/09 06:00 [medline] AID - 10.1007/s11060-009-0047-6 [doi] PST - ppublish SO - J Neurooncol. 2010 May;98(1):71-6. doi: 10.1007/s11060-009-0047-6. Epub 2009 Nov 24.